← Back to Search

Neuromodulation Device

Neuromodulation for Inflammatory Bowel Disease

Q: What criteria must one satisfy to be eligible for this clinical experiment?

<p>This trial is recruiting 10 participants with <a href="https://www.withpower.com/clinical-trials/ibd">IBD</a>, age 18-85. The specific admission requirements are: between 18 and 75 years old of either gender, compliant to protocol regulations, 6 months or longer of having the disease prior to enrollment, consenting to participate via signed informed consent form.</p>

N/A

Waitlist Available

Research Sponsored by Boomerang Medical

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed with Crohn's Disease or ulcerative colitis

Aged 18 to 75 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 year

Awards & highlights

Study Summary

This trialtested a new type of therapy to help people with inflammatory bowel disease (IBD).

Who is the study for?

Adults aged 18-75 with Inflammatory Bowel Disease for at least 6 months can join this trial if they're able to sign consent and follow the study plan. People with active infections, recent emergency surgery needs, colon issues like perforation or neoplasia, psychiatric disorders that could affect participation, a history of cancer within two years (except some skin cancers), drug abuse, or those in another trial recently cannot participate.Check my eligibility

What is being tested?

The Boom-IBD Clinical Trial is testing how well neuromodulation works as a treatment for patients with IBD. It's an early-stage study to see if the method is practical and safe before it can be tested more widely.See study design

What are the potential side effects?

Since this is a feasibility study focusing on neuromodulation in IBD patients, specific side effects are not listed but may include discomfort from the device or procedure-related complications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Crohn's Disease or ulcerative colitis.

Select...

I am between 18 and 75 years old.

Select...

I still have part or all of my colon.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Disease Activity Index

Trial Design

1Treatment groups

Experimental Treatment

Group I: TreatedExperimental Treatment1 Intervention

Patients implanted with neuromodulation

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Neuromodulation

2022

Completed Phase 4

~70

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Boomerang MedicalLead Sponsor

Media Library

Neuromodulation (Neuromodulation Device) Clinical Trial Eligibility Overview. Trial Name: NCT05414955 — N/A

Inflammatory Bowel Disease Research Study Groups: Treated

Inflammatory Bowel Disease Clinical Trial 2023: Neuromodulation Highlights & Side Effects. Trial Name: NCT05414955 — N/A

Neuromodulation (Neuromodulation Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05414955 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor accept seniors as participants?

"This study is only open to those between 18 and 85 years of age. For minors or seniors, there are 11 trials for the former demographic and 24 studies for the latter category."

Answered by AI

What criteria must one satisfy to be eligible for this clinical experiment?

"This trial is recruiting 10 participants with IBD, age 18-85. The specific admission requirements are: between 18 and 75 years old of either gender, compliant to protocol regulations, 6 months or longer of having the disease prior to enrollment, consenting to participate via signed informed consent form."

Answered by AI

Are there still vacancies in this research endeavor?

"Yes, this medical trial is actively recruiting patients. This information was first made available on October 1st and the data was most recently revised in November 17th of 2022."

Answered by AI

How many people have enrolled in this trial thus far?

"Boomerang Medical is responsible for this study and its execution at various sites, including Colon Surgeons of Charleston in Mount Pleasant, South carolina, USA and The Mount Sinai Medical Center in New york City. To begin the trial a minimum of 10 participants that meet all entry criteria are required."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Boom-IBD Clinical Trial

2022. "Boom-IBD Clinical Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05414955.

All > Ibd